# DoD Lupus, Transformative Vision Award

Source: https://welltoldgrants.com/grants/w81xwh-22-lrp-tva-dod-lupus-transformative-vision-award/  
Official notice: https://www.grants.gov/search-results-detail/340458

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make one award worth $2.5 million in total. Applications closed on September 1, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-LRP-TVA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | September 1, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $2.5 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The TVA supports applications that will fulfill an extraordinary vision for dramatically improving the quality of life of persons with lupus using an intervention at the individual and/or healthcare system level. This award requires a plan that will test and achieve the vision through the translation of research ideas which, when addressed, will result in a near-term impact on the quality of life of persons living with lupus. Applications may address various quality-of-life issues in lupus patients of any age, including but not limited to those with disproportionate health burdens. Preliminary data are required. Human subject research and clinical trials are allowed under this program announcement. The following are important aspects of the Transformative Vision Award: • Impact: The proposed research, if successful, should have a major impact on the quality of life of lupus patients. Applications should clearly and explicitly describe the potential impact(s) of the proposed study for individuals living with lupus and to convey its level of significance. The TVA supports high-risk, high-reward studies that have an intervention with the potential to make a significant, near-term impact on the quality of life of lupus patients. • Research Strategy: The scientific rationale and experimental methodology should demonstrate critical understanding and in-depth analysis of lupus. Experimental strategies may be novel or may be based on strong rationale derived from a literature review. • Focus Areas: The proposed research must address at least one of the FY22 LRP Focus Areas for the TVA. • Research Team: The research team’s background should be appropriate with respect to its ability to successfully complete the proposed work. • Consumer Advocate: Applications are required to include consumer advocate involvement. The research team must include one or more consumer advocate(s), who will be integral throughout the planning and implementation of the research project. Consumer advocates should be involved in the development of the research question, project design, oversight, recruitment, and evaluation, as well as other significant aspects of the proposed project. Interactions with other team members should be well integrated and ongoing, not limited to attending seminars and semi-annual meetings.

## Questions people ask

### Is W81XWH-22-LRP-TVA still open?

No. It closed on September 1, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Lupus, Transformative Vision Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Lupus, Transformative Vision Award?

Closed September 1, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $2.5 million in total for one award.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.